Literature DB >> 24986874

How we diagnose neutropenia in the adult and elderly patient.

Jan Palmblad1, Carlo Dufour2, Helen A Papadaki3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24986874      PMCID： PMC4077072          DOI： 10.3324/haematol.2014.110288

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Clinical presentation and management of drug-induced agranulocytosis.

Authors:  Emmanuel Andrès; Jacques Zimmer; Mustapha Mecili; Thierry Weitten; Martine Alt; Frédéric Maloisel
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

Review 2.  Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica).

Authors:  Francesca Fioredda; Michaela Calvillo; Sonia Bonanomi; Tiziana Coliva; Fabio Tucci; Piero Farruggia; Marta Pillon; Baldassarre Martire; Roberta Ghilardi; Ugo Ramenghi; Daniela Renga; Giuseppe Menna; Angelica Barone; Marina Lanciotti; Carlo Dufour
Journal:  Pediatr Blood Cancer       Date:  2011-03-29       Impact factor: 3.167

3.  Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases.

Authors:  J Bux; G Behrens; G Jaeger; K Welte
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

Review 4.  Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia.

Authors:  Helen A Papadaki; Charalampos Pontikoglou
Journal:  Expert Rev Hematol       Date:  2008-12       Impact factor: 2.929

5.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

6.  Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia.

Authors:  H A Papadaki; K Stamatopoulos; A Damianaki; C Gemetzi; A Anagnostopoulos; T Papadaki; A G Eliopoulos; G D Eliopoulos
Journal:  Br J Haematol       Date:  2005-03       Impact factor: 6.998

7.  Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Authors:  Daniel Tesfa; Tobias Gelius; Birgitta Sander; Eva Kimby; Bengt Fadeel; Jan Palmblad; Hans Hägglund
Journal:  Med Oncol       Date:  2008-02-16       Impact factor: 3.064

Review 8.  Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management.

Authors:  Daniel Tesfa; Marianne Keisu; Jan Palmblad
Journal:  Am J Hematol       Date:  2009-07       Impact factor: 10.047

9.  Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells.

Authors:  Helen A Papadaki; Aristides G Eliopoulos; Theodoros Kosteas; Claudia Gemetzi; Athina Damianaki; Helen Koutala; Juergen Bux; George D Eliopoulos
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

10.  Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.

Authors:  Friedrich Wimazal; Christa Fonatsch; Renate Thalhammer; Ilse Schwarzinger; Leonhard Müllauer; Wolfgang R Sperr; John M Bennett; Peter Valent
Journal:  Leuk Res       Date:  2007-05-16       Impact factor: 3.156
View more
  17 in total

Review 1.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 2.  An update on the diagnosis and treatment of chronic idiopathic neutropenia.

Authors:  David C Dale; Audrey A Bolyard
Journal:  Curr Opin Hematol       Date:  2017-01       Impact factor: 3.284

Review 3.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Identification of GFI1 mutations in adult patients with congenital neutropenia.

Authors:  Erasmia Boutakoglou; Maksim Klimiankou; Grigorios Tsaknakis; Elias Drakos; Julia Skokowa; Helen A Papadaki
Journal:  Ann Hematol       Date:  2022-09-16       Impact factor: 4.030

Review 6.  How I diagnose and treat neutropenia.

Authors:  David C Dale
Journal:  Curr Opin Hematol       Date:  2016-01       Impact factor: 3.284

7.  Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases.

Authors:  Rachel Mourot-Cottet; Frédéric Maloisel; François Séverac; Olivier Keller; Thomas Vogel; Martine Tebacher; Jean-Christophe Weber; Georges Kaltenbach; Jacques-Eric Gottenberg; Bernard Goichot; Jean Sibilia; Anne-Sophie Korganow; Raoul Herbrecht; Emmanuel Andrès
Journal:  Drugs Real World Outcomes       Date:  2016-12

8.  An Elderly Woman with Anti-neutrophil Antibody-positive Agranulocytosis Who Responded to High-dose Intravenous Methylprednisolone.

Authors:  Shiro Koh; Hideo Koh; Yuki Kubo; Maiko Kuroda; Mitsutaka Nishimoto; Takuro Yoshimura; Yasuhiro Nakashima; Takahiko Nakane; Hirohisa Nakamae; Masahiko Ohsawa; Masayuki Hino
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

9.  History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.

Authors:  Emmanuel Andrès; Rachel Mourot-Cottet; Frédéric Maloisel; Olivier Keller; Thomas Vogel; François Séverac; Martine Tebacher; Jacques-Eric Gottenberg; Jean-Christophe Weber; Georges Kaltenbach; Bernard Goichot; Jean Sibilia; Anne-Sophie Korganow; Raoul Herbrecht
Journal:  J Clin Med       Date:  2017-09-26       Impact factor: 4.241

10.  The JAK2 V617F mutation in isolated neutropenia.

Authors:  Stephen E Langabeer
Journal:  EXCLI J       Date:  2018-01-02       Impact factor: 4.068
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.